175 related articles for article (PubMed ID: 20215399)
1. Amount of bone loss in relation to time around the final menstrual period and follicle-stimulating hormone staging of the transmenopause.
Sowers MR; Zheng H; Jannausch ML; McConnell D; Nan B; Harlow S; Randolph JF
J Clin Endocrinol Metab; 2010 May; 95(5):2155-62. PubMed ID: 20215399
[TBL] [Abstract][Full Text] [Related]
2. Serum sex steroid levels and longitudinal changes in bone density in relation to the final menstrual period.
Crandall CJ; Tseng CH; Karlamangla AS; Finkelstein JS; Randolph JF; Thurston RC; Huang MH; Zheng H; Greendale GA
J Clin Endocrinol Metab; 2013 Apr; 98(4):E654-63. PubMed ID: 23443812
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women's Health Across the Nation (SWAN).
Greendale GA; Sowers M; Han W; Huang MH; Finkelstein JS; Crandall CJ; Lee JS; Karlamangla AS
J Bone Miner Res; 2012 Jan; 27(1):111-8. PubMed ID: 21976317
[TBL] [Abstract][Full Text] [Related]
4. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women.
Burger HG; Dudley EC; Hopper JL; Groome N; Guthrie JR; Green A; Dennerstein L
J Clin Endocrinol Metab; 1999 Nov; 84(11):4025-30. PubMed ID: 10566644
[TBL] [Abstract][Full Text] [Related]
5. Follicle stimulating hormone and its rate of change in defining menopause transition stages.
Sowers MR; Zheng H; McConnell D; Nan B; Harlow S; Randolph JF
J Clin Endocrinol Metab; 2008 Oct; 93(10):3958-64. PubMed ID: 18647816
[TBL] [Abstract][Full Text] [Related]
6. Hormone predictors of bone mineral density changes during the menopausal transition.
Sowers MR; Jannausch M; McConnell D; Little R; Greendale GA; Finkelstein JS; Neer RM; Johnston J; Ettinger B
J Clin Endocrinol Metab; 2006 Apr; 91(4):1261-7. PubMed ID: 16403818
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of bone loss in menopausal Australian-born women.
Guthrie JR; Ebeling PR; Hopper JL; Barrett-Connor E; Dennerstein L; Dudley EC; Burger HG; Wark JD
Osteoporos Int; 1998; 8(3):282-90. PubMed ID: 9797914
[TBL] [Abstract][Full Text] [Related]
8. The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN.
Sowers MR; Finkelstein JS; Ettinger B; Bondarenko I; Neer RM; Cauley JA; Sherman S; Greendale GA;
Osteoporos Int; 2003 Jan; 14(1):44-52. PubMed ID: 12577184
[TBL] [Abstract][Full Text] [Related]
9. Associations of Age at Menopause With Postmenopausal Bone Mineral Density and Fracture Risk in Women.
Shieh A; Ruppert KM; Greendale GA; Lian Y; Cauley JA; Burnett-Bowie SA; Karvonen-Guttierez C; Karlamangla AS
J Clin Endocrinol Metab; 2022 Jan; 107(2):e561-e569. PubMed ID: 34537850
[TBL] [Abstract][Full Text] [Related]
10. Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period.
Randolph JF; Zheng H; Sowers MR; Crandall C; Crawford S; Gold EB; Vuga M
J Clin Endocrinol Metab; 2011 Mar; 96(3):746-54. PubMed ID: 21159842
[TBL] [Abstract][Full Text] [Related]
11. The long-term effect of menopause on postmenopausal bone loss in Japanese women: results from a prospective study.
Okano H; Mizunuma H; Soda M; Kagami I; Miyamoto S; Ohsawa M; Ibuki Y; Shiraki M; Suzuki T; Shibata H
J Bone Miner Res; 1998 Feb; 13(2):303-9. PubMed ID: 9495525
[TBL] [Abstract][Full Text] [Related]
12. Estradiol rates of change in relation to the final menstrual period in a population-based cohort of women.
Sowers MR; Zheng H; McConnell D; Nan B; Harlow SD; Randolph JF
J Clin Endocrinol Metab; 2008 Oct; 93(10):3847-52. PubMed ID: 18647803
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal analysis of bone density in human immunodeficiency virus-infected women.
Dolan SE; Kanter JR; Grinspoon S
J Clin Endocrinol Metab; 2006 Aug; 91(8):2938-45. PubMed ID: 16735489
[TBL] [Abstract][Full Text] [Related]
14. Dietary isoflavones and bone mineral density during midlife and the menopausal transition: cross-sectional and longitudinal results from the Study of Women's Health Across the Nation Phytoestrogen Study.
Greendale GA; Tseng CH; Han W; Huang MH; Leung K; Crawford S; Gold EB; Waetjen LE; Karlamangla AS
Menopause; 2015 Mar; 22(3):279-88. PubMed ID: 25116050
[TBL] [Abstract][Full Text] [Related]
15. Quantifying the Balance Between Total Bone Formation and Total Bone Resorption: An Index of Net Bone Formation.
Shieh A; Han W; Ishii S; Greendale GA; Crandall CJ; Karlamangla AS
J Clin Endocrinol Metab; 2016 Jul; 101(7):2802-9. PubMed ID: 27336357
[TBL] [Abstract][Full Text] [Related]
16. Bone turnover markers and bone density across the menopausal transition.
Ebeling PR; Atley LM; Guthrie JR; Burger HG; Dennerstein L; Hopper JL; Wark JD
J Clin Endocrinol Metab; 1996 Sep; 81(9):3366-71. PubMed ID: 8784098
[TBL] [Abstract][Full Text] [Related]
17. Cadmium, follicle-stimulating hormone, and effects on bone in women age 42-60 years, NHANES III.
Gallagher CM; Moonga BS; Kovach JS
Environ Res; 2010 Jan; 110(1):105-11. PubMed ID: 19875111
[TBL] [Abstract][Full Text] [Related]
18. Obesity as a protective factor for postmenopausal osteoporosis.
Albala C; Yáñez M; Devoto E; Sostin C; Zeballos L; Santos JL
Int J Obes Relat Metab Disord; 1996 Nov; 20(11):1027-32. PubMed ID: 8923160
[TBL] [Abstract][Full Text] [Related]
19. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition.
Sowers MR; Eyvazzadeh AD; McConnell D; Yosef M; Jannausch ML; Zhang D; Harlow S; Randolph JF
J Clin Endocrinol Metab; 2008 Sep; 93(9):3478-83. PubMed ID: 18593767
[TBL] [Abstract][Full Text] [Related]
20. Bayesian estimation of associations between identified longitudinal hormone subgroups and age at final menstrual period.
Jiang B; Sammel MD; Freeman EW; Wang N
BMC Med Res Methodol; 2015 Dec; 15():106. PubMed ID: 26677844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
